about unitaid - global health innovative technology fund 5_3... · • common vision &...

AboutUnitaid

8December2017SanneFournier-Wendes,SeniorAdvisortotheED

1

Agenda

1

Unitaidoverview

Ourportfolio

CollaborationwithGHITFund

1

2

3

Unitaidoverview

3

Growthindevelopmentassistance

3

Source:IHME(InstituteforHealthMetricsandEvaluation)

JointHealthSystemPlatform2006

Developmentassistanceforhealth($B)

ParisDeclaration

AccraAgendaForAction

4

Innovation ScalabilityAccess

Unitaid’smissionrelieson3strategicobjectives

4

Maximizetheeffectivenessoftheglobalhealthresponsebycatalyzingequitableaccesstobetterhealthproducts

Linkingpipelinestofrontlines

Overcomingmarketbarriers

Creatingconditionsforscale-up

Unitaid playsaroleat3criticalmoments

5

Objectives Innovation ScalabilityAccess

Moment2Productisadopted

Moment3Productisscaled-up

Moment1ProductisavailableProd

uctcoverage

Maximizetheeffectivenessofthe

globalhealthresponse...

...bycatalyzingequitableaccess...

...tobetterhealthproducts

6

Upstream

Systems

Innovation&Availability

Devices

Supply&Delivery

Medicines

Quality

Demand&Adoption

Affordability

Unitaidconnectstheupstreamtothedownstream

HIV/AIDS Tuberculosis Malaria

Downstream

PDPsGates

FoundationIndustryAcademia OthersGHITFund

…

6

Ensuringaccessbyovercomingmarketbarriers

7

Unitaid's OperatingModel

Developproposals Developgrant

Signature&Disbursement

Identifyopportunitiesforintervention

Callforproposals

Selectionofareasforintervention

ii iiii

Go-aheadofproposals Finalapproval

Boardinvolvement

Decisiongate

Developdiseasenarratives

Implement&transition/close

7

8

Partnerengagementiskeythroughentireprocess

8

Anticipateandrespondtocountryneeds

Anticipateupstreaminnovation

Ensurereadinesstoscale-upincludingfunding

Ourportfolio

10

Unitaid’sCoreInvestmentAreas

10

Tuberculosis

TESTPREVENT TREAT

HIV Malaria

HIVco-infections,incl.Hepatitis

Cross-cutting

11

Unitaid’sPortfolioasatOct2017

11

40grants US$1bio.

22

5

8

5

492m49%151m

15%

252m25%

107m11%

12

TB:Newpaediatricformulation

12

Unitaidhasintroducedfirstchild-friendlyTBmedicine

Childrenhavebeenunder-treatedfordecades

• ~10%ofallTBcasesoccuramongchildren

• Atleast1millionchildrenbecomeillwithTBeachyear

• TBmedicineshavebeenaroundsince1950s– butnochild-friendlyversion

• 2010:RevisedWHOrecommendationforTBtreatmentinchildrenbutnomanufacturerswereresponding

• Unitaid&itspartners(TBAlliance)havebroughtchild-friendlyfixeddosecombinationtomarket

Todayprocuredinmorethan70countries

13

Malaria:InjectableArtesunate - adramaticreductioninchildmortality

13

24.5

10.5

1.7

14x

2011 20212015

Numberofvialsprocured(m)

Unitaid &partners Partners

66kchildren’slivessaved/year

ROI>100

CollaborationwithGHITFund

15

Partnerengagement- GHIT

15

• Commonvision&interests:bringaccesstonewhealthtechnologies(e.g.drugs,diagnostics)withpotentialforgamechangingimpactindevelopingworld

• ParticipationinGHITannualpartnermeetingin2016andinR&DForuminDecember2017

• Bi-lateraldiscussions:3meetingsinLondon,NewYorkUNGA2017andGenevaOct2017

• MappinginprocessofpotentialGHITinvestmentsthatcouldbetransitionedtoUnitaid,e.g.‒ Commonpartners/stakeholders(GatesFoundation,Otsuka,TBAlliance)‒ Commonprioritycountries(e.g.Uganda,Tanzania,BurkinaFaso)‒ Commonpriorityareas(e.g.Malariainchildren,Tuberculosis)

EngagementbetweenGHIT&Unitaidandareasofcontinuedcollaboration

16

Upstream

Systems

Innovation&Availability

Devices

Supply&Delivery

Medicines

Quality

Demand&Adoption

Affordability

AreaofvaluechainsuitedtocollaborationwithGHIT

HIV/AIDS Tuberculosis Malaria

Downstream

PDPsGates

FoundationIndustryAcademia OthersGHITFund

…

16

1717

Anyquestions?Thankyou